S Squared Technology LLC Lowers Position in DocGo Inc. (NASDAQ:DCGO)

S Squared Technology LLC trimmed its position in shares of DocGo Inc. (NASDAQ:DCGO) by 15.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,382,386 shares of the company’s stock after selling 255,000 shares during the quarter. DocGo accounts for approximately 2.4% of S Squared Technology LLC’s portfolio, making the stock its 18th largest holding. S Squared Technology LLC’s holdings in DocGo were worth $5,861,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Mariner LLC boosted its holdings in DocGo by 58.6% during the fourth quarter. Mariner LLC now owns 47,938 shares of the company’s stock worth $203,000 after purchasing an additional 17,721 shares during the last quarter. Barclays PLC lifted its position in shares of DocGo by 14.5% during the 4th quarter. Barclays PLC now owns 154,456 shares of the company’s stock worth $655,000 after buying an additional 19,533 shares in the last quarter. Summit Investment Advisors Inc. boosted its stake in shares of DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after buying an additional 2,968 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of DocGo in the fourth quarter valued at approximately $527,000. Finally, Renaissance Technologies LLC grew its holdings in shares of DocGo by 583.4% in the fourth quarter. Renaissance Technologies LLC now owns 350,600 shares of the company’s stock valued at $1,487,000 after acquiring an additional 299,300 shares in the last quarter. Institutional investors own 56.44% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on DCGO. Deutsche Bank Aktiengesellschaft cut DocGo from a “buy” rating to a “hold” rating and cut their price objective for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. Stifel Nicolaus cut their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Finally, Needham & Company LLC restated a “buy” rating and set a $4.00 price target on shares of DocGo in a research report on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $4.89.

DocGo Price Performance

Shares of DCGO opened at $2.19 on Thursday. DocGo Inc. has a 1 year low of $2.12 and a 1 year high of $5.68. The stock’s fifty day moving average price is $3.36 and its two-hundred day moving average price is $3.81. The firm has a market cap of $223.34 million, a PE ratio of 7.82, a PEG ratio of 14.16 and a beta of 1.12.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.